Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical- and Cost-effectiveness, Safety and Acceptability of Sequential Vitrectomy and Cataract Surgery vs Combined Phacovitrectomy for Rhegmatogenous Retinal Detachment: Randomised Equivalence Trial

NCT06997874 is registered in ClinicalTrials.gov with Queen's University, Belfast as lead sponsor.

NCT NCT06997874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06997874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical- and Cost-effectiveness, Safety and Acceptability of Sequential Vitrectomy and Cataract Surgery vs Combined Phacovitrectomy for Rhegmatogenous Retinal Detachment: Randomised Equivalence Trial
Lead sponsor
Queen's University, Belfast
Phase
Phase 3
Overall status
Recruiting
Start date
May 16, 2025
Completion date
May 8, 2028
Enrollment
276 (estimated)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

rhegmatogenous retinal detachment